These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1930060)

  • 1. A double-blind placebo controlled evaluation of acupressure in the treatment of motion sickness.
    Warwick-Evans LA; Masters IJ; Redstone SB
    Aviat Space Environ Med; 1991 Aug; 62(8):776-8. PubMed ID: 1930060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P6 acupressure increases tolerance to nauseogenic motion stimulation in women at high risk for PONV.
    Alkaissi A; Ledin T; Odkvist LM; Kalman S
    Can J Anaesth; 2005; 52(7):703-9. PubMed ID: 16103382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P6 acupressure reduces symptoms of vection-induced motion sickness.
    Hu S; Stritzel R; Chandler A; Stern RM
    Aviat Space Environ Med; 1995 Jul; 66(7):631-4. PubMed ID: 7575310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of acupressure and acustimulation bands for the prevention of motion sickness.
    Miller KE; Muth ER
    Aviat Space Environ Med; 2004 Mar; 75(3):227-34. PubMed ID: 15018290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study.
    Marcus DA; Furman JM
    Med Sci Monit; 2006 Jan; 12(1):PI1-7. PubMed ID: 16369474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morning sickness control in early pregnancy by Neiguan point acupressure.
    de Aloysio D; Penacchioni P
    Obstet Gynecol; 1992 Nov; 80(5):852-4. PubMed ID: 1407927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a portable acustimulation device in controlling seasickness.
    Bertolucci LE; DiDario B
    Aviat Space Environ Med; 1995 Dec; 66(12):1155-8. PubMed ID: 8747609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin for motion sickness: clinical evaluation.
    Knox GW; Woodard D; Chelen W; Ferguson R; Johnson L
    Laryngoscope; 1994 Aug; 104(8 Pt 1):935-9. PubMed ID: 8052077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose ondansetron for reducing motion sickness in highly susceptible subjects.
    Muth ER; Elkins AN
    Aviat Space Environ Med; 2007 Jul; 78(7):686-92. PubMed ID: 17679566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acupressure relieves the symptoms of motion sickness and reduces abnormal gastric activity.
    Stern RM; Jokerst MD; Muth ER; Hollis C
    Altern Ther Health Med; 2001; 7(4):91-4. PubMed ID: 11452572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind placebo controlled study of cinnarizine in the prophylaxis of seasickness.
    Hargreaves J
    Practitioner; 1980 May; 224(1343):547-50. PubMed ID: 6999486
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness.
    Muth ER; Jokerst M; Stern RM; Koch KL
    Aviat Space Environ Med; 1995 Nov; 66(11):1041-5. PubMed ID: 8588792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorpheniramine for motion sickness.
    Buckey JC; Alvarenga D; Cole B; Rigas JR
    J Vestib Res; 2004; 14(1):53-61. PubMed ID: 15156097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorpheniramine and ephedrine in combination for motion sickness.
    Buckey JC; Alvarenga DL; MacKenzie TA
    J Vestib Res; 2007; 17(5-6):301-11. PubMed ID: 18626140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of transdermally administered scopolamine in preventing motion sickness.
    McCauley ME; Royal JW; Shaw JE; Schmitt LG
    Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acupressure and motion sickness.
    Bruce DG; Golding JF; Hockenhull N; Pethybridge RJ
    Aviat Space Environ Med; 1990 Apr; 61(4):361-5. PubMed ID: 2339974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
    Noy S; Shapira S; Zilbiger A; Ribak J
    Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of antimotion sickness drugs.
    Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of expectations to motion sickness symptoms and gastric activity.
    Williamson MJ; Thomas MJ; Stern RM
    J Psychosom Res; 2004 Jun; 56(6):721-6. PubMed ID: 15193970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promethazine as a motion sickness treatment: impact on human performance and mood states.
    Cowings PS; Toscano WB; DeRoshia C; Miller NE
    Aviat Space Environ Med; 2000 Oct; 71(10):1013-22. PubMed ID: 11051308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.